Transcript
Page 1: Caring for the bariatric patient with obstructive sleep apnea

Crit Care Nurs Clin N Am 16 (2004) 311–317

Caring for the bariatric patient with obstructive sleep apnea

Margaret M. Ecklund, MS, RNa,*, Stefan A. Kurlak, RRTb

aPulmonary Medicine, Rochester General Hospital, 1425 Portland Avenue, Rochester, NY 14621, USAbRespiratory Care, Rochester General Hospital, 1425 Portland Avenue, Rochester, NY 14621, USA

The call came from the staff nurse: ‘‘We had an nasal continuous positive airway pressure (NCPAP)

admission this afternoon from the Medical Intensive

Care Unit, and he weighs 748 lb (340 kg) and does

not fit in the bed. What do we do’’? So began the

journey of PM with the multidisciplinary team on the

step down pulmonary unit.

The care of the bariatric patient in acute care

presents many challenges, including strategies for

management of obstructive sleep apnea (OSA). The

plan of care for such patients includes a host of

strategies to manage multisystem and organizational

issues. Using a case study to highlight important

aspects of such care, this article explores the etiology

and treatment of OSA.

Case history and progress

PM, a 39-year-old male with a history of severe

obesity and a body mass index (BMI) of 91 kg/m2,

was admitted because of a fall at home secondary to

weakness from the onset of pneumonia. Because he

was unable to get up, the Emergency Medical System

(EMS) was alerted, and he was transported to the

hospital on an oversized cart.

PM lived alone and had been housebound for the

last 4 months. His weight gain worsened as his

dyspnea and depression increased, causing a further

decline in his functional status. He owned his own

business and had been working from his home.

PM’s history was significant for severe obesity,

hypertension, depression, OSA, cardiomyopathy, and

deep vein thrombosis (DVT). He had been using

0899-5885/04/$ – see front matter D 2004 Elsevier Inc. All right

doi:10.1016/j.ccell.2004.03.004

* Corresponding author.

E-mail address: [email protected]

(M.M. Ecklund).

with supplemental oxygen to treat OSA that had been

diagnosed by a polysomnogram (sleep study) the

previous year. He had also been evaluated for gastric

bypass surgery and was on a waiting list for the

procedure. Although he was knowledgeable of obe-

sity treatment strategies, his ability to control his

intake was limited.

The bariatric bed on which PM was transported

accommodated up to 500 lb (227.3 kg). Considering

his height (74 in [188 cm]), weight, and girth, the bed

was inappropriate. For example, his legs were resting

on chairs next to the bed.

The first challenge for the multidisciplinary team

was to provide PM a suitable sleep surface. The

necessary data included weight, height, girth, skin

integrity, and the ability to move independently in

and out of bed. A Barimax 2 (Kinetic Concepts,

San Antonio, TX) was selected because it accom-

modated up to 850 lb (386 kg). It was wide enough

to allow turning, had a built in scale, and a low-

pressure sleep surface. The staff coordinated PM’s

move to the new bed, and he appeared relieved once

comfortably situated.

A formal psychiatric consultation helped PM

identify his feelings about his body image and

limitations. He described feelings of despair and

frustration over lack of progress and hunger. In

addition to talking with PM, the psychiatrist recom-

mended clonazepam (Klonipin) until he improved,

and an increase in sertaline (Zoloft), which he had

been on before admission.

The evaluation of PM’s respiratory status was

done early in the admission on 4 L of oxygen with

NCPAP. An arterial blood gas (ABG) after a night on

NCPAP, demonstrated respiratory acidosis (pH 7.30,

PaCO2 66, PaO2 66, SaO2 90, HCO3 31). The team

selected bi-level ventilation with a nasal mask to treat

s reserved.

Page 2: Caring for the bariatric patient with obstructive sleep apnea

M.M. Ecklund, S.A. Kurlak / Crit Care Nurs Clin N Am 16 (2004) 311–317312

the nocturnal hypercarbia and OSA. To evaluate

nocturnal desaturation, overnight oximetry studies

were conducted. The first study on 4 L of nasal

oxygen without bi-level therapy showed significant

desaturation, with average oxygen saturation of 79%.

Subsequent studies performed on bi-level ventilation

with supplemental oxygen showed an improvement

in oxygenation and decrease in PaCO2. The studies

revealed that the most effective therapy was humidi-

fied bi-level ventilation with the following settings:

inspiratory positive airway pressure (IPAP) of 15 cm

H2O and 6 cm H2O of positive end expiratory

pressure (PEEP) or expiratory pressure (EPAP) de-

livered with 6 L of supplemental oxygen through a

nasal mask. Throughout the hospitalization, PM reli-

ably used the bi-level therapy with the addition of

humidity and nasal strips to improve nasal patency.

Mobilization in the early weeks was a challenge.

Because PM could not achieve independent sitting

balance, physical therapists worked to improve mus-

cle strength so that balance could improve and PM

could get out of bed. To help mobilize PM, an

inflatable transfer device (Hover Matt Technology,

Allentown, PA) was selected to assist with moving

PM up in bed and to reposition him as necessary.

Initially, six staff members were needed to provide

Table 1

Components of PM’s plan of care

Problem Goals

Psychosocial Ability to control aspects of care and daily

activity

Nutrition Caloric intake to meet daily energy needs;

Consistent weight loss

Respiratory SpO2 > 90%

Daytime wakefulness without lethargy

Skin integrity Healed, intact skin

Elimination Urine continence;

Bowel continence

Circulation No deep venous thromboses

Mobility Ambulation without falls

Educational Knowledge of disease process, management,

and treatment options

turning and to achieve the supine position. Until he

regained leg strength, two people were required to

move his legs for care and positioning. A sheet was

folded and placed under his legs to achieve leverage

with positioning, while his trunk was turned with a

separate lift sheet. This technique protected staff from

injury and was more comfortable for PM. He began

the daily process of getting out of bed but was re-

luctant to try any new activity if the caregivers did not

project confidence and the ability to listen to his fears

and observations.

Although a referral to skilled nursing facilities

(SNF) was initiated by the social worker once PM’s

functional state began to stabilize, the complexity and

cost of his care (noninvasive positive pressure venti-

lation [NIPPV], full assisted daily living help and

equipment rental) made acceptance impossible. An

updated referral to a bariatric surgeon was made for

gastric bypass. The care manager completed the

referral request, including the necessary cardiac,

pulmonary, psychiatry, nutritional, and social service

evaluations and the third party payer approval.

PM’s mobility improved and he lost a total of

135 lbs (61 kg). Two months after his admission,

PM was transferred directly to the hospital where his

Roux-En-Y gastric bypass surgery would be per-

Stratgies

Patient setting own goals & schedules;

Knowledge and trust of team members

Limited calorie diet, with adequate protein intake;

Diet preferences determined;

Food and intake teaching

Noninvasive bi-level ventilation at HS, with

supplemental oxygen;

Oxygen via nasal prongs daily

Local care to wounds with protective creams and

petroleum gauze [14];

Low pressure mattress;

Chair cushion & commode padding;

Turning schedule, pillowcases in skin folds

Indwelling catheter until mobile;

Assistive device to hold urinal when catheter removed;

Commode of adequate size;

Stool softener

Anticoagulation with warfarin

Progressive ambulation

Walker of adequate size;

Supplemental oxygen;

Shoes for support;

Appropriate size wheelchair

Educate about obesity and diet;

Educate about OSA

Page 3: Caring for the bariatric patient with obstructive sleep apnea

M.M. Ecklund, S.A. Kurlak / Crit Care Nurs Clin N Am 16 (2004) 311–317 313

formed. This required that specialty vendors be con-

tacted regarding PM’s weight and girth to ensure that

the proper transport equipment was available. Al-

though a freight-type transport cart was required for

ambulance transportation, PM was brought through

the hospital to the ambulance in a wheelchair to main-

tain his dignity.

PM’s bariatric surgery and recovery were success-

ful. One year later his weight is 411 lb (187 kg), he is

running his business successfully, and is an active

participant in support groups for other people con-

sidering bariatric surgery. Aspects of PM’s plan of

care are summarized in Table 1.

Obesity

Obesity is derived from the Latin word meaning

overeat. The modern definition of obesity is disease

of excess body fat. Despite common perceptions and

prejudices, obesity is a disease, not a character flaw,

cosmetic aberration, or personality disorder [1]. In the

year 2000, 38.8 million Americans were obese: an

estimated 61% of all Americans have a BMI >30 kg/

m2, according to the Centers for Disease Control

(CDC). The CDC also projects a cost of >117 billion

dollars (yearly) in health care costs for obese indi-

viduals [2].

Obesity is the result of the body consuming more

energy than it uses. It results from physiologic, social,

and cultural factors. Genes play an important role in

the regulation of body weight, and many processes in

the brain and gastrointestinal tract influence appetite.

Eating patterns are affected by satiety centers in the

hypothalamus and pituitary glands that respond to

high fat stores and hunger. Many metabolic processes

involving hormones and proteins have an impact on

obesity. In addition, dietary patterns of modern soci-

ety accompanied by more sedentary lifestyles pro-

mote weight gain and obesity [3].

Definition of obesity

The BMI (Box 1) is considered the best measure

for gauging body fat. It is a mathematic expres-

Box 1. Steps to calculate Body Mass Index(BMI) kg/m2 [4]

1. [Weight (pounds) x 703]/Height(inches)

2. Divide result by height (inches)

sion of weight adjusted for height. A BMI of 25 to

29.9 kg/m2 is considered overweight; obesity is a

BMI of 30 kg/m2 or higher. Morbid obesity is an

ambiguous term, with reference to greater than

100 pounds over the desirable weight of the individ-

ual. The National Institutes of Health consensus panel

defines severe obesity as a BMI greater than or equal

to 50 kg/m2 [3,4]. A limitation of the BMI measure-

ment is that it does not differentiate the type of weight

(fat versus muscle). Muscular individuals can be

misclassified as overweight [3].

Other measures of obesity include waist circum-

ference, waist/hip ratio, and anthropometry. A waist

measurement of greater than 31.5 in (80 cm) for

women and greater than 37 in (94 cm) for men in-

dicates health risk. The waist/hip ratio is determined

by dividing waist by hip size. The lower the ratio, the

better. Heart disease risk increases for women with

ratios greater than 0.8. Anthropometry is the mea-

surement of skin fold thickness, usually done with

forceps at the triceps. It determines how much weight

is due to muscle or fat [4].

By these definitions PM, with a BMI of 91 kg/m2,

was severely obese. He demonstrated comorbitities as

well. To understand the rationale for the treatment

plan for PM, some of the pathophysiologic processes

associated with obesity and complications are dis-

cussed in the following sections.

Physiologic processes influencing obesity

Leptin is a hormone that is released by fat cells

and the stomach and is, in part, responsible for food

intake, storage, and conversion into energy [2]. Lep-

tin is released by adipocytes, or fat cells, in propor-

tion to the size of the adipocyte cell. Adipocytes store

energy when calories are in excess and mobilize

energy when needs exceed intake. In rodents, leptin

reduces energy intake and increases energy expendi-

ture. Because this would translate to weight loss in

obese humans with high plasma leptin concentra-

tions, leptin resistance is a suggested explanation of

human obesity [3]. Leptin treatment for weight loss

has been unsuccessful except in those individuals

with leptin deficiency [5].

The inability to use insulin efficiently is also

associated with obesity. Resistin is a hormone that

is produced by fat cells and produces insulin resist-

ance [2]. If insulin is used ineffectively and hyper-

glycemia results, a host of complications can result

including impaired wound healing, infections, and

organ failure [6]. The importance of ‘‘tight’’ glucose

control was recently demonstrated in a study of

critically ill surgical patients. The investigators found

Page 4: Caring for the bariatric patient with obstructive sleep apnea

M.M. Ecklund, S.A. Kurlak / Crit Care Nurs Clin N Am 16 (2004) 311–317314

that the use of insulin infusions to attain glucose

levels less than or equal to 110 mg/dL resulted in

reduced morbidity and mortality in critically ill sur-

gical patients [6]. The study suggested that improved

glucose control can be a strategy to compensate for

the effects of insulin resistance in obese patients.

Although PM did not have diabetes, the plan of care

included weight loss and activity to compensate for

his altered metabolism and insulin use.

Other complications of obesity

Complications of obesity can be categorized into

weight related complications, metabolic obesity, and

organ-related obesity [1]. Weight-related complica-

tions include degenerative joint disease, respiratory

compromise, skin changes, and intraabdominal

pressure compromise (varicose veins, hemorrhoids).

Metabolic obesity presents with neurohormonal

and behavioral symptoms (stress intolerance, seden-

tary lifestyle, or use of tobacco, alcohol, or drugs),

substrate overload (type 2 diabetes, dyslipidemia,

cholelithiasis), and thrombogenic manifestations.

Organ-related pathology includes presence of adipose

tissue, liver fibrosis, and kidney dysfunction [1]. PM

experienced a number of weight and metabolic com-

plications, including respiratory compromise, skin

breakdown, and sedentary lifestyle. One of the most

serious complications was OSA, which will be dis-

cussed further.

Obstructive sleep apnea

Definition

OSA occurs when there is partial or complete

upper airway collapse during sleep. During periods

of OSA, episodes of oxyhemoglobin, desaturation,

and transient nocturnal arousals and awakening create

sleep disturbances resulting in daytime sleepiness [7].

OSA, recognized over 30 years ago, is measured in

terms of obstructive apnea and hypopnea episodes

per hour of sleep resulting in an apnea-hypopnea

index (AHI). Central sleep apnea is characterized by

repeated episodes of apnea or hypopnea resulting

from deceased neural output to responding motor

neurons without airflow obstruction. One out of every

five adults with a mean BMI of 25 to 28 kg/m2 has at

least mild OSA, whereas 1 of every 15 has mild sleep

apnea. One interesting fact regarding OSA is that

most patients with OSA snore, but most individuals

who snore do not have frank OSA [8]. The preva-

lence of OSA can be predicted from increased neck

circumference, hypertension, habitual snoring, noc-

turnal gagging, and choking [7].

The modifiable risk factors of OSA are over-

weight and obesity, alcohol consumption, tobacco

use, nasal congestion, and estrogen depletion in

menopause. Weight loss is the single most significant

factor in reducing OSA [7]. Undiagnosed OSA with

or without symptoms is independently associated

with increased likelihood of hypertension, cardiovas-

cular disease, stroke, daytime sleepiness, motor ve-

hicle accidents, and diminished quality of life [7].

For PM, it was essential that the team treat his

OSA effectively. Based on overnight oximetry re-

sults, bi-level support with nasal mask was selected.

Mechancial ventilation for obstructive sleep apnea

Mechanical treatments for OSA in the category of

NIPPV include continuous positive airway pressure

(CPAP) and bi-level ventilation. The most common

treatment for OSA is NCPAP. The difference between

NIPPV systems is that bi-level ventilation uses dif-

ferent pressures on inspiration and expiration, where-

as NCPAP operates with one continuous level of

pressure during both inspiration and expiration. The

decision to choose one system over the other in part

centers on the amount of pressure needed to keep

the airways open and whether nighttime hypoventi-

lation is present with apnea episodes. In situations in

which high levels of pressure are required, mean

airway pressures can be lowered using bi-level sys-

tems versus CPAP systems and potentially making

the patient more comfortable. The amount of CPAP

required to eliminate apnea and maintain oxygenation

commonly ranges from 5 to 20 cm H2O pressure [9].

Another choice in NIPPV for treating OSA is a bi-

level device that cycles between an IPAP and EPAP

(or PEEP). The inspiratory phase can be initiated by

the patient or by the backup rate programmed into

the device. The backup rate delivers a set number of

breaths in the event of apnea. With bi-level devices,

the difference in pressure between the inspiratory and

expiratory phases dictates the resulting tidal volume.

Bi-level settings are generally expressed as inspira-

tory pressure over expiratory pressure (ie,10/5) and

generally require a pressure difference of 5 cm H2O

between settings. Breaths on the bi-level system are

similar to pressure supported breaths on conventional

ventilators. Increasing the inspiratory pressure while

maintaining the same level of expiratory pressure

yields an increase in expected tidal volume. For

example, increasing the settings from 10/5 to 15/5

results in a higher level of support on inspiration.

Conversely, if both the inspiratory and expiratory

Page 5: Caring for the bariatric patient with obstructive sleep apnea

M.M. Ecklund, S.A. Kurlak / Crit Care Nurs Clin N Am 16 (2004) 311–317 315

pressures are increased the same amount, there will

be no difference in the pressure gradient and therefore

an increased tidal volume is not expected [10]. The

fundamental difference between CPAP and bi-level

ventilation is that in CPAP the levels remain constant,

whereas in bi-level, the levels of pressure vary on

inspiration and expiration. The point to be empha-

sized is that NIPPV treats but does not cure OSA

[11]. These methods of noninvasive ventilation are

delivered through a variety of devices.

Noninvasive interface devices: selection and

considerations

In treating OSA, one of the prevalent issues the

health care professional faces is patient compliance,

specifically, wearing the interface device consistently.

Interface devices are masks or pillows used to deliver

NIPPV to the nose or mouth. Therefore, in addition to

providing the optimal settings for the patient, every

effort is made ensure comfort. The use of nasal

masks, full-face masks, and nasal pillows are all con-

sidered. Allowing the patient to have a variety of

options contributes to compliance [11]. An adequate

face seal is important. Because the bi-level devices

compensate for leaks, some leak is acceptable. It is

important to prevent leaks around the eyes and avoid

resting the nasal mask on the lip. Different headgear

may be used to ensure a snug fit without causing

undue pressure. Skin breakdown at the bridge of the

nose is a risk with nasal and full-face masks. Vigilant

assessment by respiratory therapists and nurses helps

prevent the development of this complication. Pre-

vention strategies include mask repositioning, appli-

cation of hydrocolloid dressings, or padding with

gauze dressing. Selection of a full-face mask is done

cautiously because aspiration is possible if the patient

vomits and cannot remove the mask before doing so.

Patients with decreased mental status and those

unable to remove the mask if needed are poor can-

didates for full-face mask ventilation. Collaboration

among care providers can help determine risk, strate-

gies for nasogastric tube use, or decisions regarding

feeding. In general, because of the potential for as-

piration, patients should not consume oral intake

while on NIPPV. It is important that the nurse and

respiratory therapist collaborate in care planning so

that ventilator-free times are provided for eating and

other activities. Alternate oxygen delivery devices

may be required during periods off the NIPPV.

Another factor to consider is humidity because

positive airway pressure can result in the airways be-

coming dry and uncomfortable. A simple humidi-

fication system can make the difference between

patient compliance and noncompliance. The addition

of a flow-by humidification system to the NIPPV will

reduce the drying effect of the continual gas flow. PM

found that he was more comfortable when humidity

was used and that nasal strips helped with nasal

patency. As with PM, it is important to remember that

compliance with NIPPV is often related to comfort.

NIPPV interface devices include nasal mask, full-

face mask, or nasal pillows. All interface devices

have a leak port with a single limb circuit to allow

exhalation [11].

Evaluating noninvasive positive pressure ventilation

Evaluation of the effectiveness of NIPPV is ac-

complished with a combination of patient reporting

(ie, daytime sleepiness) and physical and laboratory

data. Arterial blood gases provide information related

to PaCO2 levels and are especially helpful to deter-

mine the effectiveness of therapy during sleep. Pulse

oximetry helps identify desaturation episodes and

may be used continuously throughout the sleep

period or intermittently, as the patient condition

requires. More subtle signs of effectiveness over time

can be resolution of right-sided heart failure symp-

toms, including decreased peripheral edema. Once

NIPPV requirements are determined, qualification for

approval of insurance coverage is sought [11]. Many

insurers adhere to the Medicare approval process,

which dictates an algorhythmic approach to diagnosis

and therapy requirements. A formal sleep study may

be necessary to qualify for reimbursement.

Other therapeutic treatment options for obstructive

sleep apnea

Other treatments for OSA are generally catego-

rized into three groups: behavior modification and

medical and surgical treatments. The least invasive of

the treatments is behavior modification, beginning

with the obvious benefit of weight loss followed by

avoidance of alcohol and sedatives and altering sleep

positioning. Switching from supine positioning to

lateral positioning can reduce obstruction symptoms.

Medical options include medications; however, phar-

macologic therapy has not shown definitive improve-

ment in symptoms [12].

Dental appliances can treat OSA. The mandibular

positioning appliance attaches to one or both dental

arches (the maxilla and mandible). The appliance

facilitates the forward advancement and downward

rotation of the mandible. The tongue retaining device

works by holding the tongue anteriorly while the

Page 6: Caring for the bariatric patient with obstructive sleep apnea

M.M. Ecklund, S.A. Kurlak / Crit Care Nurs Clin N Am 16 (2004) 311–317316

patient is sleeping. These devices are specifically de-

signed for each patient [12].

Surgical treatment for OSA is usually reserved for

when other treatments have failed. The most common

surgery is palatal surgery in which the airway is

modified so that it is located above the base of the

tongue. Uvulopalato-pharynoyoplasty surgery has

been successful in reducing snoring but has not

demonstrated efficacy in reducing episodes of ap-

nea-hypopnea [12].

Bariatric surgery options

Surgery is reserved for cases of extreme obesity

(BMI >40 kg/m2) or obese patients with BMI >35 kg/

m2 if comorbities are present. The gastric bypass or

Roux-en-Y is the most commonly performed gastric

bypass procedure in the United States. It can be done

either laparoscopically or via open incision. The

upper portion of the stomach is stapled to create a

reservoir of approximately 10 to 30mL. The reservoir

connects directly to the jejunum in a Roux-en-Y man-

ner. By restricting the stomach capacity and bypass-

ing the stomach and proximal small intestine, caloric

quantity is reduced and nutritional absorption is

limited. Weight loss is averaged at 60% to 70% of

excess body weight up to one year after the surgery.

Mortality rates are 1.3% to 1.5% in contrast to higher

rates in the 1980s. Complications associated with

gastric bypass include wound infection, incisional

hernia, peritonitis with anastamosis leak, vitamin

and mineral deficiencies, and osteoporosis [3,13].

Rigorous selection of appropriate patients is done

by surgical centers to ensure patient understanding of

weight loss and postoperative commitment to suc-

cess. Failure of nonsurgical methods of weight loss,

absence of endocrine abnormality contributing to

severe obesity, and psychological stability, with the

absence of drug and alcohol abuse, are all standard

criteria for surgical consideration. A complete preop-

erative assessment is completed before surgery ac-

ceptance. Active peptic ulcer disease is an absolute

contraindication. The incidence of cholelithiasis is

15% to 25% in severely obese patients, therefore

screening of patients who have their gall bladder

intact is recommended, with cholecystectomy sug-

gested with surgical intervention. A limited diet is

resumed within 1 day postoperatively, with gradual

increase to a pureed diet for 4 weeks. Postoperative

follow up with the surgical team and a nutritionist

assists the individual to ensure adequate protein and

caloric intake [13].

PM was a candidate for the laparoscopic approach

Roux-En-Y procedure as determined by the preopera-

tive evaluation data. PM’s procedure was performed

without complications and his recovery was unevent-

ful and proceeded as planned.

Summary

Caring for the bariatric patient requires a compre-

hensive approach that extends beyond airway man-

agement. The case of PM highlights additional issues

related to the care of the obese patient with OSA.

Critical issues include skin care, mobilization, nutri-

tion, and psychologic support. Although obesity is

common and more bariatric patients are likely to be

hospitalized for related complications, few evidence-

based guidelines exist to direct care. The selection

and efficacy of bariatric equipment and techniques

for mobilizing these patients have yet to be deter-

mined scientifically.

Care for the bariatric patient is complex and

requires coordination and skill. The advanced prac-

tice nurse is uniquely prepared to take a lead role.

Without doubt, comprehensive and systematic atten-

tion to the many details of the plan of care are critical

if good outcomes such as those attained by PM are to

be realized. At the core of the care is the importance

of establishing trust and maintaining the individual’s

dignity. In the case of PM, the multidisciplinary team

partnered with him to achieve his goals for weight

loss and a return to health and a productive life.

References

[1] Kral JG. Morbidity of severe obesity. Surg Clin North

Am 2001;81:1039–57.

[2] National Center for Chronic Disease Prevention and

Health Promotion. Overweight and Obesity. Nutri-

tion and physical activity. Available at: http://www.

cdc.gov/nccdphp/dnpa/obesity/index.htm. Accessed

May 30, 2003.

[3] Racette SB, Deusinger SS, Deusinger RH. Obesity:

overview of prevalence, etiology and treatment. Phys

Ther 2003;83:276–88.

[4] Well Connected: weight control and diet. Available

at: http://www.well-connected.com/. Accessed Octo-

ber 1, 2002.

[5] Bryson JM. The future of leptin and leptin analogues in

the treatment of obesity. Diabetes, Obesity and Metab-

olism 2000;7:83–9.

[6] VandenBerghe G, Wouters P, Weekers F, et al. Inten-

sive insulin therapy in critically ill patients. N Engl J

Med 2001;345:1359–67.

[7] Tsai WH, Remmers JE, Brant R, Flemons W, Davies J,

Macarthur C. A decision rule for diagnostic testing in

Page 7: Caring for the bariatric patient with obstructive sleep apnea

M.M. Ecklund, S.A. Kurlak / Crit Care Nurs Clin N Am 16 (2004) 311–317 317

obstructive sleep apnea. Am J Respir Crit Care Med

2003;167:1427–32.

[8] Young T, Peppard PE, Gottlieb DJ. Epidemiology of

obstructive sleep apnea: a population health perspec-

tive. Am J Respir Crit Care Med 2002;165:1217–39.

[9] Dobbin KR, Strollo PJ. Obstructive sleep apnea: rec-

ognition and management considerations for the aged

patient. AACN Clin Issues 2002;13:103–13.

[10] Perkins LA, Shortall SP. Ventilation without intuba-

tion. RN 2000;63:34–8.

[11] Mehta S, Hill NS. Noninvasive ventilation. Am J Respir

Crit Care Med 2001;163:540–57.

[12] Goldberg R. Treatment of obstructive sleep apnea,

other than with continuous positive airway pressure.

Curr Opin Pulm Med 2000;6:496–500.

[13] Brolin RE. Gastric bypass. Surg Clin North Am 2001;

81:1077–95.

[14] Agency for Health Care Policy and Research. Pressure

ulcers in adults: prediction & prevention. Clinical prac-

tice guideline. Rockville (MD): US Department of

Health and Human Services Agency for Health Care

Policy and Research; 1992. p. 20–1.